体外診断薬の品質管理市場：提供、販売業者、用途、エンドユーザー別-2025-2030年の世界予測

体外診断薬の品質管理市場の2023年の市場規模は13億7,000万米ドル、2024年には14億8,000万米ドルに達すると予測され、CAGR 8.34%で成長し、2030年には24億1,000万米ドルに達すると予測されています。

体外診断薬（IVD）の品質管理とは、血液検査やその他のラボ分析など、生体外で実施される診断検査の正確性と信頼性を確保するために使用されるプロセスと材料を指します。この市場の必要性は、検査の正確性を確保し、偽陽性や偽陰性を減らし、厳格な規制基準への準拠を確実にする上で重要な役割を果たすことにあります。調査用途は臨床検査室、病院、学術・研究機関など多岐にわたり、最終用途は病気の進行のモニタリング、病状の診断、薬物療法の管理にまで及ぶ。主な成長促進要因としては、慢性疾患の増加、検査室自動化の進展、ポイントオブケア検査の採用拡大などが挙げられます。分子診断や品質管理プロセスにおける人工知能の統合といった最近の技術革新は、特に個別化医療への需要が高まる中で、新たな機会を提供しています。こうした機会を活用するため、企業は研究開発に投資し、既存の診断プラットフォームと新たな診断プラットフォームの両方に対応する、より洗練された適応性の高い品質管理ソリューションを開発する必要があります。とはいえ、市場は、品質管理製品に関連する高コスト、規制上のハードル、異なる診断機器間での標準化の欠如など、一定の限界と課題に直面しています。これらの課題は、中小企業にとって参入障壁となり、市場成長の妨げとなる可能性があります。このような課題にもかかわらず、市場浸透を高めるためには、技術革新は特に費用対効果の高いソリューションと異なるメーカーの機器間の相互運用性に焦点を当てるべきです。全体として、体外診断用医薬品の品質管理市場は、急速な技術進歩と厳しい監督によって特徴付けられており、各社は競争力を維持するために継続的な適応と革新を求められています。的を絞った研究開発への投資と戦略的提携や買収は、このダイナミックで進化するセクターにおける成長をさらに促進し、市場での存在感を高めることができます。

市場力学：急速に進化する体外診断薬の品質管理市場の主要市場インサイトを公開

体外診断薬の品質管理市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。こうした動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 慢性疾患や感染症の流行と体外診断の必要性
  • ポイントオブケア診断技術と第三者による品質管理に対する需要の高まり
  • 診断機器やサービスの安全性を確保するための政府規制
• 市場抑制要因
  • IVD品質管理サービスのコスト高
• 市場機会
  • 体外診断用医薬品にスマートな品質管理を導入するための研究開発活動
  • シリコン技術と多項目コントロールの技術的進歩
• 市場の課題
  • 体外診断用医薬品の承認に関する厳しい規制と不正確さの問題

ポーターの5つの力：体外診断薬の品質管理市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することで、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：体外診断薬の品質管理市場における外部からの影響の把握

外部マクロ環境要因は、体外診断薬の品質管理市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析体外診断薬の品質管理市場における競合情勢の把握

体外診断薬の品質管理市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス体外診断薬の品質管理市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、体外診断薬の品質管理市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨体外診断薬の品質管理市場における成功への道筋を描く

体外診断薬の品質管理市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 慢性疾患および感染症の蔓延と体外診断の必要性
    • ポイントオブケア診断技術とサードパーティの品質管理に対する需要の高まり
    • 診断機器およびサービスの安全性を確保するための政府規制
  • 抑制要因
    • IVD品質管理サービスの高コスト
  • 機会
    • 体外診断用スマート品質管理の導入に向けた研究開発活動
    • シリコン技術とマルチアナライト制御の技術的進歩
  • 課題
    • 体外診断検査製品の承認に関する厳格な規制と不正確さの問題
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 体外診断薬の品質管理市場：提供別

• データ管理ソリューション
• 品質保証サービス
• 品質管理製品
  • 血清/血漿ベースのコントロール
  • 尿による検査
  • 全血ベースのコントロール

第7章 体外診断薬の品質管理市場販売元別

• メーカー
• サードパーティ制御メーカー
  • 独立したメーカーによる管理
  • 機器固有のコントロール

第8章 体外診断薬の品質管理市場：用途別

• 臨床化学
• 凝固または止血
• 血液学
• 免疫化学
• 微生物学
• 分子診断

第9章 体外診断薬の品質管理市場：エンドユーザー別

• 臨床検査室
• 病院
• 調査・学術機関

第10章 南北アメリカの体外診断薬の品質管理市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域の体外診断薬の品質管理市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカの体外診断薬の品質管理市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
  • インド子会社がISO13485認証を取得
  • ヴェルフェン、Immucorの買収を完了
  • EDX、IVD製品開発会社Torax Biosciencesの買収を完了
  • シーメンスヘルシナーズとユニラボ、患者ケア向上のための最新の診断検査インフラ構築に向けた戦略的提携を開始
  • ULソリューションズが体外診断の範囲を拡大
  • キアゲン、研究室での自動サンプリングのためのIVDプラットフォームを発表
  • InDevRがシリーズ B資金調達で900万米ドルを調達し、bioMerieuxと提携
  • VeranexがDeviciaとClarvinを買収し、IVDおよび医療機器の規制、品質、臨床の専門知識を拡大
• 戦略分析と提言

企業一覧

• Abbott Laboratories
• Agilent Technologies, Inc.
• Becton, Dickinson and Company
• Bio-Rad Laboratories, Inc.
• Bio-Techne Corporation
• bioMerieux Inc.
• CalibreScientific Global Distribution, Inc.
• Danaher Corporation
• Devyser AB
• DiaSorin S.p.A.
• F. Hoffmann-La Roche Ltd.
• Fortress Diagnostics
• Grifols, S.A.
• Hologic, Inc.
• Illumina, Inc.
• LGC Limited
• Maine Molecular Quality Controls, Inc.
• Micro Bio Logics, Inc.
• Microbix Biosystems Inc.
• Ortho-Clinical Diagnostics, Inc.
• Qiagen N.V.
• Quidel Corporation
• Randox Laboratories Ltd.
• Seegene Inc.
• Siemens AG
• Streck, Inc.
• Sun Diagnostics, LLC
• Sysmex Corporation
• Thermo Fisher Scientific, Inc.
• ZeptoMetrix Corporation

LIST OF FIGURES

• FIGURE 1. IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET RESEARCH PROCESS
• FIGURE 2. IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. AMERICAS IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 17. UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. ASIA-PACIFIC IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. ASIA-PACIFIC IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 23. IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET DYNAMICS
• TABLE 7. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DATA MANAGEMENT SOLUTIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY ASSURANCE SERVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY SERUM/PLASMA-BASED CONTROLS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY URINE-BASED CONTROLS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY WHOLE-BLOOD-BASED CONTROLS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OEM, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY INDEPENDENT MANUFACTURER CONTROLS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY INSTRUMENT-SPECIFIC CONTROLS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY CLINICAL CHEMISTRY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY COAGULATION OR HEMOSTASIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY HEMATOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY IMMUNOCHEMISTRY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY MICROBIOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY CLINICAL LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 31. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 32. AMERICAS IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 33. AMERICAS IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 34. AMERICAS IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
• TABLE 35. AMERICAS IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
• TABLE 36. AMERICAS IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 37. AMERICAS IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 38. AMERICAS IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 39. ARGENTINA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 40. ARGENTINA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 41. ARGENTINA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
• TABLE 42. ARGENTINA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
• TABLE 43. ARGENTINA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 44. ARGENTINA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 45. BRAZIL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 46. BRAZIL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 47. BRAZIL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
• TABLE 48. BRAZIL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
• TABLE 49. BRAZIL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 50. BRAZIL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 51. CANADA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 52. CANADA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 53. CANADA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
• TABLE 54. CANADA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
• TABLE 55. CANADA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 56. CANADA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 57. MEXICO IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 58. MEXICO IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 59. MEXICO IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
• TABLE 60. MEXICO IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
• TABLE 61. MEXICO IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 62. MEXICO IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 63. UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 64. UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 65. UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
• TABLE 66. UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
• TABLE 67. UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 68. UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 69. UNITED STATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 70. ASIA-PACIFIC IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 71. ASIA-PACIFIC IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 72. ASIA-PACIFIC IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
• TABLE 73. ASIA-PACIFIC IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
• TABLE 74. ASIA-PACIFIC IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 75. ASIA-PACIFIC IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 76. ASIA-PACIFIC IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 77. AUSTRALIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 78. AUSTRALIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 79. AUSTRALIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
• TABLE 80. AUSTRALIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
• TABLE 81. AUSTRALIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 82. AUSTRALIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 83. CHINA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 84. CHINA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 85. CHINA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
• TABLE 86. CHINA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
• TABLE 87. CHINA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 88. CHINA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 89. INDIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 90. INDIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 91. INDIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
• TABLE 92. INDIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
• TABLE 93. INDIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 94. INDIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 95. INDONESIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 96. INDONESIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 97. INDONESIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
• TABLE 98. INDONESIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
• TABLE 99. INDONESIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 100. INDONESIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 101. JAPAN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 102. JAPAN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 103. JAPAN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
• TABLE 104. JAPAN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
• TABLE 105. JAPAN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 106. JAPAN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 107. MALAYSIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 108. MALAYSIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 109. MALAYSIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
• TABLE 110. MALAYSIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
• TABLE 111. MALAYSIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 112. MALAYSIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 113. PHILIPPINES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 114. PHILIPPINES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 115. PHILIPPINES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
• TABLE 116. PHILIPPINES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
• TABLE 117. PHILIPPINES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 118. PHILIPPINES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 119. SINGAPORE IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 120. SINGAPORE IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 121. SINGAPORE IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
• TABLE 122. SINGAPORE IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
• TABLE 123. SINGAPORE IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 124. SINGAPORE IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 125. SOUTH KOREA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 126. SOUTH KOREA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 127. SOUTH KOREA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
• TABLE 128. SOUTH KOREA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
• TABLE 129. SOUTH KOREA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 130. SOUTH KOREA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 131. TAIWAN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 132. TAIWAN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 133. TAIWAN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
• TABLE 134. TAIWAN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
• TABLE 135. TAIWAN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 136. TAIWAN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 137. THAILAND IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 138. THAILAND IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 139. THAILAND IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
• TABLE 140. THAILAND IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
• TABLE 141. THAILAND IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 142. THAILAND IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 143. VIETNAM IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 144. VIETNAM IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 145. VIETNAM IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
• TABLE 146. VIETNAM IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
• TABLE 147. VIETNAM IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 148. VIETNAM IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 149. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 150. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 151. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
• TABLE 152. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
• TABLE 153. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 154. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 155. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 156. DENMARK IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 157. DENMARK IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 158. DENMARK IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
• TABLE 159. DENMARK IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
• TABLE 160. DENMARK IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 161. DENMARK IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 162. EGYPT IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 163. EGYPT IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 164. EGYPT IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
• TABLE 165. EGYPT IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
• TABLE 166. EGYPT IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 167. EGYPT IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 168. FINLAND IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 169. FINLAND IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 170. FINLAND IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
• TABLE 171. FINLAND IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
• TABLE 172. FINLAND IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 173. FINLAND IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 174. FRANCE IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 175. FRANCE IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 176. FRANCE IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
• TABLE 177. FRANCE IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
• TABLE 178. FRANCE IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 179. FRANCE IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 180. GERMANY IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 181. GERMANY IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 182. GERMANY IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
• TABLE 183. GERMANY IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
• TABLE 184. GERMANY IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 185. GERMANY IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 186. ISRAEL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 187. ISRAEL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 188. ISRAEL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
• TABLE 189. ISRAEL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
• TABLE 190. ISRAEL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 191. ISRAEL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 192. ITALY IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 193. ITALY IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 194. ITALY IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
• TABLE 195. ITALY IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
• TABLE 196. ITALY IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 197. ITALY IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 198. NETHERLANDS IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 199. NETHERLANDS IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 200. NETHERLANDS IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
• TABLE 201. NETHERLANDS IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
• TABLE 202. NETHERLANDS IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 203. NETHERLANDS IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 204. NIGERIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 205. NIGERIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 206. NIGERIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
• TABLE 207. NIGERIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
• TABLE 208. NIGERIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 209. NIGERIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 210. NORWAY IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 211. NORWAY IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 212. NORWAY IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
• TABLE 213. NORWAY IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
• TABLE 214. NORWAY IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 215. NORWAY IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 216. POLAND IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 217. POLAND IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 218. POLAND IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
• TABLE 219. POLAND IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
• TABLE 220. POLAND IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 221. POLAND IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 222. QATAR IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 223. QATAR IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 224. QATAR IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
• TABLE 225. QATAR IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
• TABLE 226. QATAR IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 227. QATAR IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 228. RUSSIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 229. RUSSIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 230. RUSSIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
• TABLE 231. RUSSIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
• TABLE 232. RUSSIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 233. RUSSIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 234. SAUDI ARABIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 235. SAUDI ARABIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 236. SAUDI ARABIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
• TABLE 237. SAUDI ARABIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
• TABLE 238. SAUDI ARABIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 239. SAUDI ARABIA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 240. SOUTH AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 241. SOUTH AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 242. SOUTH AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
• TABLE 243. SOUTH AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
• TABLE 244. SOUTH AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 245. SOUTH AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 246. SPAIN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 247. SPAIN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 248. SPAIN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
• TABLE 249. SPAIN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
• TABLE 250. SPAIN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 251. SPAIN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 252. SWEDEN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 253. SWEDEN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 254. SWEDEN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
• TABLE 255. SWEDEN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
• TABLE 256. SWEDEN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 257. SWEDEN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 258. SWITZERLAND IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 259. SWITZERLAND IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 260. SWITZERLAND IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
• TABLE 261. SWITZERLAND IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
• TABLE 262. SWITZERLAND IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 263. SWITZERLAND IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 264. TURKEY IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 265. TURKEY IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 266. TURKEY IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
• TABLE 267. TURKEY IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
• TABLE 268. TURKEY IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 269. TURKEY IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 270. UNITED ARAB EMIRATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 271. UNITED ARAB EMIRATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 272. UNITED ARAB EMIRATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
• TABLE 273. UNITED ARAB EMIRATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
• TABLE 274. UNITED ARAB EMIRATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 275. UNITED ARAB EMIRATES IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 276. UNITED KINGDOM IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
• TABLE 277. UNITED KINGDOM IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QUALITY CONTROL PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 278. UNITED KINGDOM IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DISTRIBUTOR, 2018-2030 (USD MILLION)
• TABLE 279. UNITED KINGDOM IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY THIRD-PARTY CONTROL MANUFACTURERS, 2018-2030 (USD MILLION)
• TABLE 280. UNITED KINGDOM IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 281. UNITED KINGDOM IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 282. IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 283. IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET, FPNV POSITIONING MATRIX, 2023

The In-Vitro Diagnostics Quality Control Market was valued at USD 1.37 billion in 2023, expected to reach USD 1.48 billion in 2024, and is projected to grow at a CAGR of 8.34%, to USD 2.41 billion by 2030.

In-Vitro Diagnostics (IVD) Quality Control refers to the processes and materials used to ensure accuracy and reliability in diagnostic tests performed outside the living body, such as blood tests and other lab analyses. This market's necessity lies in the critical role it plays in ensuring test accuracy, reducing false positives/negatives, and ensuring compliance with stringent regulatory standards. Applications range across clinical laboratories, hospitals, and academic/research institutions, with an end-use scope extending to monitoring disease progression, diagnosis of medical conditions, and drug therapy management. Key growth drivers include the increasing prevalence of chronic diseases, advancements in laboratory automation, and growing adoption of point-of-care testing. Recent technological innovations like molecular diagnostics and the integration of artificial intelligence in quality control processes offer fresh opportunities, especially as the demand for personalized medicine grows. To capitalize on these opportunities, companies should invest in R&D to develop more sophisticated, adaptive quality control solutions that address both existing and emerging diagnostic platforms. Nevertheless, the market faces certain limitations and challenges, including high costs associated with quality control products, regulatory hurdles, and a lack of standardization across different diagnostic devices. These challenges can hinder market growth by creating barriers to entry for smaller players. Despite these challenges, innovation should particularly focus on cost-effective solutions and interoperability between devices from different manufacturers to enhance market penetration. Overall, the IVD quality control market is characterized by rapid technological advancements and stringent oversight, requiring players to continuously adapt and innovate to maintain their competitive edge. Investment in targeted R&D, coupled with strategic partnerships and acquisitions, can further drive growth and increase market presence in this dynamic and evolving sector.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving In-Vitro Diagnostics Quality Control Market

The In-Vitro Diagnostics Quality Control Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Prevalence of chronic and infectious diseases and need for in-vitro diagnostics
  • Growing demand for point-of-care diagnostic technologies and third-party quality controls
  • Government regulations to ensure the safety of diagnostics devices and services
• Market Restraints
  • High cost of IVD quality control services
• Market Opportunities
  • R&D activities to introduce smart quality control for in-vitro diagnostics
  • Technological advancement in silicon technology and multianalyte controls
• Market Challenges
  • Stringent regulations for approval of IVD test products and inaccuracy issues

Porter's Five Forces: A Strategic Tool for Navigating the In-Vitro Diagnostics Quality Control Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the In-Vitro Diagnostics Quality Control Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the In-Vitro Diagnostics Quality Control Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the In-Vitro Diagnostics Quality Control Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the In-Vitro Diagnostics Quality Control Market

A detailed market share analysis in the In-Vitro Diagnostics Quality Control Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the In-Vitro Diagnostics Quality Control Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the In-Vitro Diagnostics Quality Control Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the In-Vitro Diagnostics Quality Control Market

A strategic analysis of the In-Vitro Diagnostics Quality Control Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the In-Vitro Diagnostics Quality Control Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Agilent Technologies, Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Bio-Techne Corporation, bioMerieux Inc., CalibreScientific Global Distribution, Inc., Danaher Corporation, Devyser AB, DiaSorin S.p.A., F. Hoffmann-La Roche Ltd., Fortress Diagnostics, Grifols, S.A., Hologic, Inc., Illumina, Inc., LGC Limited, Maine Molecular Quality Controls, Inc., Micro Bio Logics, Inc., Microbix Biosystems Inc., Ortho-Clinical Diagnostics, Inc., Qiagen N.V., Quidel Corporation, Randox Laboratories Ltd., Seegene Inc., Siemens AG, Streck, Inc., Sun Diagnostics, LLC, Sysmex Corporation, Thermo Fisher Scientific, Inc., and ZeptoMetrix Corporation.

Market Segmentation & Coverage

This research report categorizes the In-Vitro Diagnostics Quality Control Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Offering, market is studied across Data Management Solutions, Quality Assurance Services, and Quality Control Products. The Quality Control Products is further studied across Serum/Plasma-Based Controls, Urine-Based Controls, and Whole-Blood-Based Controls.
• Based on Distributor, market is studied across OEM and Third-Party Control Manufacturers. The Third-Party Control Manufacturers is further studied across Independent Manufacturer Controls and Instrument-Specific Controls.
• Based on Application, market is studied across Clinical Chemistry, Coagulation or Hemostasis, Hematology, Immunochemistry, Microbiology, and Molecular Diagnostics.
• Based on End-User, market is studied across Clinical Laboratories, Hospitals, and Research & Academic Institutes.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Prevalence of chronic and infectious diseases and need for in-vitro diagnostics
    • 5.1.1.2. Growing demand for point-of-care diagnostic technologies and third-party quality controls
    • 5.1.1.3. Government regulations to ensure the safety of diagnostics devices and services
  • 5.1.2. Restraints
    • 5.1.2.1. High cost of IVD quality control services
  • 5.1.3. Opportunities
    • 5.1.3.1. R&D activities to introduce smart quality control for in-vitro diagnostics
    • 5.1.3.2. Technological advancement in silicon technology and multianalyte controls
  • 5.1.4. Challenges
    • 5.1.4.1. Stringent regulations for approval of IVD test products and inaccuracy issues
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. In-Vitro Diagnostics Quality Control Market, by Offering

• 6.1. Introduction
• 6.2. Data Management Solutions
• 6.3. Quality Assurance Services
• 6.4. Quality Control Products
  • 6.4.1. Serum/Plasma-Based Controls
  • 6.4.2. Urine-Based Controls
  • 6.4.3. Whole-Blood-Based Controls

7. In-Vitro Diagnostics Quality Control Market, by Distributor

• 7.1. Introduction
• 7.2. OEM
• 7.3. Third-Party Control Manufacturers
  • 7.3.1. Independent Manufacturer Controls
  • 7.3.2. Instrument-Specific Controls

8. In-Vitro Diagnostics Quality Control Market, by Application

• 8.1. Introduction
• 8.2. Clinical Chemistry
• 8.3. Coagulation or Hemostasis
• 8.4. Hematology
• 8.5. Immunochemistry
• 8.6. Microbiology
• 8.7. Molecular Diagnostics

9. In-Vitro Diagnostics Quality Control Market, by End-User

• 9.1. Introduction
• 9.2. Clinical Laboratories
• 9.3. Hospitals
• 9.4. Research & Academic Institutes

10. Americas In-Vitro Diagnostics Quality Control Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific In-Vitro Diagnostics Quality Control Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa In-Vitro Diagnostics Quality Control Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
  • 13.3.1. Indian Subsidiary Acquires ISO13485 Certification
  • 13.3.2. Werfen Completes Acquisition of Immucor
  • 13.3.3. EDX Completes Acquisition of IVD Products Developer Torax Biosciences
  • 13.3.4. Siemens Healthineers and Unilabs Launch Strategic Partnership For Latest Diagnostic Testing Infrastructure To Improve Patients' Care
  • 13.3.5. UL Solutions Expands Scope For In Vitro Diagnostics
  • 13.3.6. Qiagen Unveils IVD Platform For Automated Sampling In Laboratories
  • 13.3.7. InDevR Raises $9 Million in Series B Financing and Partners with bioMerieux
  • 13.3.8. Veranex Acquires Devicia and Clarvin, Expanding Regulatory, Quality, and Clinical Expertise for IVD and Medical Devices
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. Agilent Technologies, Inc.
• 3. Becton, Dickinson and Company
• 4. Bio-Rad Laboratories, Inc.
• 5. Bio-Techne Corporation
• 6. bioMerieux Inc.
• 7. CalibreScientific Global Distribution, Inc.
• 8. Danaher Corporation
• 9. Devyser AB
• 10. DiaSorin S.p.A.
• 11. F. Hoffmann-La Roche Ltd.
• 12. Fortress Diagnostics
• 13. Grifols, S.A.
• 14. Hologic, Inc.
• 15. Illumina, Inc.
• 16. LGC Limited
• 17. Maine Molecular Quality Controls, Inc.
• 18. Micro Bio Logics, Inc.
• 19. Microbix Biosystems Inc.
• 20. Ortho-Clinical Diagnostics, Inc.
• 21. Qiagen N.V.
• 22. Quidel Corporation
• 23. Randox Laboratories Ltd.
• 24. Seegene Inc.
• 25. Siemens AG
• 26. Streck, Inc.
• 27. Sun Diagnostics, LLC
• 28. Sysmex Corporation
• 29. Thermo Fisher Scientific, Inc.
• 30. ZeptoMetrix Corporation